Literature DB >> 7691630

Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

J R Crowther1, C A Rowe, R Butcher.   

Abstract

This paper is the first to describe characterization of monoclonal antibodies (MAbs) against a South African Territories 2 (SAT 2) foot-and-mouth disease virus (isolate Rho 1/48). Twelve MAbs which neutralized homologous virus were characterized in indirect and sandwich ELISA using purified Rho 1/48 virus particles, subunits, trypsin-treated, and chemically denatured virus. All the MAbs inhibited haemagglutination by parental virus. Binding of the MAbs to 73 SAT 2 field isolates was measured in a sandwich ELISA and defined four distinct antigenic regions. Preliminary characterization of escape mutants selected with some of the MAbs using virus neutralization tests, ELISA, and amino acid sequencing is included. MAbs 2, 25, 40, 48 and 64, reacted with a linear epitope on the VP1 loop region. An amino acid change at position 149 (valine to glutamic acid) was detected in mutants selected by MAb 2 and 40 and this eliminated binding and neutralization by all the other MAb. This epitope was conformation-dependent and was conserved in all 73 isolates of SAT 2 examined. Escape mutants isolated with MAb 41 and 44, had changes at positions 156 (glycine to aspartic acid), or 158 (serine to leucine) respectively. These MAbs bound with Rho 1/48 only out of 73 field strain viruses studies and the reactions of MAbs from the other groups was unaltered. MAb 27, 28 and 37 reacted with a conformation-dependent epitope on VP1 which was not conserved in field isolates. All mutants selected by these MAbs had a single amino acid substitution at position 149 (valine to alanine). The same change was always found in field isolates which did not bind MAbs from this group. MAb 11 reacted with a linear epitope associated with amino acids 147 or 148 on VP1 and showed similar binding characteristics to a conformation dependent MAb 7, no amino acid residue changes were found within VP1 for monoclonal antibody 7 mutants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691630      PMCID: PMC2271387          DOI: 10.1017/s0950268800057083

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  F BROWN; B CARTWRIGHT
Journal:  Nature       Date:  1963-09-21       Impact factor: 49.962

2.  Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus strains using monoclonal antibodies.

Authors:  A R Samuel; N J Knowles; G D Samuel; J R Crowther
Journal:  Biologicals       Date:  1991-10       Impact factor: 1.856

3.  Haemagglutination by type SAT 2 foot-and-mouth disease viruses.

Authors:  J C Booth; T W Pay
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

4.  Four independent antigenic determinants on the capsid polypeptides of aphthovirus.

Authors:  J M Haresnape; D McCahon
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891

5.  Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.

Authors:  N Parry; G Fox; D Rowlands; F Brown; E Fry; R Acharya; D Logan; D Stuart
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

6.  Hybridoma cell lines secreting monoclonal antibodies to foot-and-mouth disease virus type Asia-1.

Authors:  G Butchaiah; B U Rao
Journal:  Acta Virol       Date:  1989-03       Impact factor: 1.162

7.  Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.

Authors:  B H Robertson; D O Morgan; D M Moore
Journal:  Virus Res       Date:  1984-09       Impact factor: 3.303

8.  Rapid isolation of monoclonal hybridoma cultures by a 'fusion-cloning' method: the requirement for aminopterin.

Authors:  R N Butcher; T U Obi; K C McCullough
Journal:  Biologicals       Date:  1991-07       Impact factor: 1.856

9.  Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.

Authors:  E J Ouldridge; P V Barnett; N R Parry; A Syred; M Head; M M Rweyemamu
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

10.  Chemical basis of antigenic variation in foot-and-mouth disease virus.

Authors:  D J Rowlands; B E Clarke; A R Carroll; F Brown; B H Nicholson; J L Bittle; R A Houghten; R A Lerner
Journal:  Nature       Date:  1983 Dec 15-21       Impact factor: 49.962

View more
  11 in total

1.  Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus.

Authors:  H G van Rensburg; L H Nel
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  An overview on ELISA techniques for FMD.

Authors:  Li-na Ma; Jie Zhang; Hao-tai Chen; Jian-hua Zhou; Yao-zhong Ding; Yong-sheng Liu
Journal:  Virol J       Date:  2011-09-04       Impact factor: 4.099

3.  Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates.

Authors:  D T Haydon; A D Bastos; N J Knowles; A R Samuel
Journal:  Genetics       Date:  2001-01       Impact factor: 4.562

4.  Antigenic analysis of SAT 2 serotype foot-and-mouth disease virus isolates from Zimbabwe using monoclonal antibodies.

Authors:  F L Davidson; J R Crowther; J Nqindi; N J Knowles; S J Thevasagayam; C J Van Vuuren
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

5.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

Authors:  S Curry; C C Abrams; E Fry; J C Crowther; G J Belsham; D I Stuart; A M King
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus.

Authors:  Richard Reeve; Belinda Blignaut; Jan J Esterhuysen; Pamela Opperman; Louise Matthews; Elizabeth E Fry; Tjaart A P de Beer; Jacques Theron; Elizabeth Rieder; Wilna Vosloo; Hester G O'Neill; Daniel T Haydon; Francois F Maree
Journal:  PLoS Comput Biol       Date:  2010-12-09       Impact factor: 4.475

7.  Characterization of foot-and-mouth disease viruses (FMDVs) from Ugandan cattle outbreaks during 2012-2013: evidence for circulation of multiple serotypes.

Authors:  Alice Namatovu; Kirsten Tjørnehøj; Graham J Belsham; Moses T Dhikusooka; Sabenzia N Wekesa; Vincent B Muwanika; Hans R Siegismund; Chrisostom Ayebazibwe
Journal:  PLoS One       Date:  2015-02-09       Impact factor: 3.240

8.  Production of foot-and-mouth disease virus SAT2 VP1 protein.

Authors:  Mpho Victoria Mamabolo; Jacques Theron; Francois Maree; Michael Crampton
Journal:  AMB Express       Date:  2020-01-07       Impact factor: 3.298

9.  Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.

Authors:  Pamela A Opperman; Lia S Rotherham; Jan Esterhuysen; Bryan Charleston; Nicholas Juleff; Alejandra V Capozzo; Jacques Theron; Francois F Maree
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

10.  Evaluation and use of in-silico structure-based epitope prediction with foot-and-mouth disease virus.

Authors:  Daryl W Borley; Mana Mahapatra; David J Paton; Robert M Esnouf; David I Stuart; Elizabeth E Fry
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.